1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. TRAVERE THERAPEUTICS INC
Travere Therapeutics Inc XNAS: TVTX

Travere Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Weak Stock
about

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is...

Read More
15.48 -0.05 (-0.32%)
38.79% Fall from 52W High
983.7K
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Travere Therapeutics Inc is on 01 Aug 2025 for the purpose of Travere Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
9.5 / 100
Momentum Score
Technically Bearish
31.8 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
34
1Yr Price target upside is 121%
15 analysts

7

S

12

W

2

O

1

T

SWOT Analysis

Travere Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..